Health
Immunosuppressive therapies may be linked to severe COVID-19 in those with multiple sclerosis – News-Medical.Net
A new study examines the associations between immunosuppressive disease-modifying therapies (DMTs) used in MS with adverse outcomes in an international cohort of…
In the ongoing coronavirus disease 2019 (COVID-19) pandemic, caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), patients with coexisting medical conditions have been noted to be at a higher risk of progressive and severe disease. Patients with multiple sclerosis (MS), who are often on immunosuppressive therapy, may be among these high-risk groups.
A new study, released on the medRxiv* preprint server, examines the associations between immunosuppressive disease-modifying…
-
Noosa News21 hours agoData shows 73 serving and former Australian Defence Force members died by suicide in 2023
-
Noosa News22 hours agoBidding for a good cause
-
Noosa News21 hours agoAustralian-funded PALM scheme liaison workers say they went months without pay
-
Noosa News21 hours agoMurray Watt slams Queensland LNP renewable energy policy